Tara S Kent1, Mark P Callery, Charles M Vollmer. 1. Department of Surgery, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA 02215, USA. tkent@bidmc.harvard.edu
Abstract
OBJECTIVES: Although infrequent, Grade C postoperative pancreatic fistulae (POPF) following pancreaticoduodenectomy (PD) are morbid and potentially lethal. Traditional management of a disrupted pancreaticojejunostomy (PJ) anastomosis consists of either wide external drainage or completion pancreatectomy. The aim of this study is to describe an alternative management approach to PJ dehiscence after PD. METHODS: A bridge stent technique is employed in the setting of a disrupted PJ anastomosis. Upon re-exploration, a 5-Fr or 8-Fr silastic feeding tube stent is placed across a gap between the jejunal enterotomy and the pancreatic duct, and secured with an absorbable suture at both ends. Depending upon the degree of local inflammation, this may be externalized by coursing the stent downstream through the pancreaticobiliary drainage limb in a Witzel fashion. RESULTS: Over 8 years and 357 PDs with duct-to-mucosa PJ reconstruction, seven ISGPF (International Study Group on Pancreatic Fistula) Grade C fistulae occurred (2%). Two patients ultimately died secondary to POPF (neither anastomosis was dehisced). The described technique was used in the other five patients, all of whom had evidence of a dehisced PJ anastomosis. All originally had at least two or three recognized risk factors for POPF development (high-risk pathology, soft gland, duct diameter ≤ 3 mm, estimated blood loss ≥ 1000 ml). All patients survived this complication and were discharged from hospital. There have been no longterm external fistulae, nor any recognized PJ strictures or remnant atrophy (median follow-up: 10.7 months). CONCLUSIONS: In the context of a dehisced pancreaticojejunal anastomosis, the bridge stent technique is a safe and effective method of management that contributes to diminished mortality and helps to salvage pancreatic function.
OBJECTIVES: Although infrequent, Grade C postoperative pancreatic fistulae (POPF) following pancreaticoduodenectomy (PD) are morbid and potentially lethal. Traditional management of a disrupted pancreaticojejunostomy (PJ) anastomosis consists of either wide external drainage or completion pancreatectomy. The aim of this study is to describe an alternative management approach to PJ dehiscence after PD. METHODS: A bridge stent technique is employed in the setting of a disrupted PJ anastomosis. Upon re-exploration, a 5-Fr or 8-Fr silastic feeding tube stent is placed across a gap between the jejunal enterotomy and the pancreatic duct, and secured with an absorbable suture at both ends. Depending upon the degree of local inflammation, this may be externalized by coursing the stent downstream through the pancreaticobiliary drainage limb in a Witzel fashion. RESULTS: Over 8 years and 357 PDs with duct-to-mucosa PJ reconstruction, seven ISGPF (International Study Group on Pancreatic Fistula) Grade C fistulae occurred (2%). Two patients ultimately died secondary to POPF (neither anastomosis was dehisced). The described technique was used in the other five patients, all of whom had evidence of a dehisced PJ anastomosis. All originally had at least two or three recognized risk factors for POPF development (high-risk pathology, soft gland, duct diameter ≤ 3 mm, estimated blood loss ≥ 1000 ml). All patients survived this complication and were discharged from hospital. There have been no longterm external fistulae, nor any recognized PJ strictures or remnant atrophy (median follow-up: 10.7 months). CONCLUSIONS: In the context of a dehisced pancreaticojejunal anastomosis, the bridge stent technique is a safe and effective method of management that contributes to diminished mortality and helps to salvage pancreatic function.
Authors: Jordan M Winter; John L Cameron; Kurtis A Campbell; David C Chang; Taylor S Riall; Richard D Schulick; Michael A Choti; JoAnn Coleman; Mary B Hodgin; Patricia K Sauter; Christopher J Sonnenday; Christopher L Wolfgang; Michael R Marohn; Charles J Yeo Journal: J Gastrointest Surg Date: 2006-11 Impact factor: 3.452
Authors: Claudio Bassi; Christos Dervenis; Giovanni Butturini; Abe Fingerhut; Charles Yeo; Jakob Izbicki; John Neoptolemos; Michael Sarr; William Traverso; Marcus Buchler Journal: Surgery Date: 2005-07 Impact factor: 3.982
Authors: Wande B Pratt; Shishir K Maithel; Tsafrir Vanounou; Zhen S Huang; Mark P Callery; Charles M Vollmer Journal: Ann Surg Date: 2007-03 Impact factor: 12.969
Authors: Ronnie T P Poon; Sheung Tat Fan; Chung Mau Lo; Kelvin K Ng; Wai Key Yuen; Chun Yeung; John Wong Journal: Ann Surg Date: 2007-09 Impact factor: 12.969
Authors: Philippe Bachellier; Elie Oussoultzoglou; Edoardo Rosso; Radu Scurtu; Ioan Lucescu; Akihiko Oshita; Daniel Jaeck Journal: Arch Surg Date: 2008-10
Authors: David Fuks; Guillaume Piessen; Emmanuel Huet; Marion Tavernier; Philippe Zerbib; Francis Michot; Michel Scotte; Jean-Pierre Triboulet; Christophe Mariette; Laurence Chiche; Ephraïm Salame; Philippe Segol; François-René Pruvot; François Mauvais; Horace Roman; Pierre Verhaeghe; Jean-Marc Regimbeau Journal: Am J Surg Date: 2008-09-07 Impact factor: 2.565
Authors: U F Wellner; B Kulemann; H Lapshyn; J Hoeppner; O Sick; F Makowiec; D Bausch; Ulrich Theodor Hopt; T Keck Journal: J Gastrointest Surg Date: 2014-01-22 Impact factor: 3.452
Authors: F Jasmijn Smits; Hjalmar C van Santvoort; Marc G Besselink; Marilot C T Batenburg; Robbert A E Slooff; Djamila Boerma; Olivier R Busch; Peter P L O Coene; Ronald M van Dam; David P J van Dijk; Casper H J van Eijck; Sebastiaan Festen; Erwin van der Harst; Ignace H J T de Hingh; Koert P de Jong; Johanna A M G Tol; Inne H M Borel Rinkes; I Quintus Molenaar Journal: JAMA Surg Date: 2017-06-01 Impact factor: 14.766